$10,000 of AMPHENOL CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Resolution of USMCA Labor Dispute"
You can find more data on corporate lobbying on Quiver Quantitative.
APH Insider Trading Activity
APH insiders have traded $APH stock on the open market 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:
- RICHARD ADAM NORWITT (President & CEO) has made 0 purchases and 3 sales selling 130,775 shares for an estimated $18,709,065.
- ROBERT LIVINGSTON purchased 10,000 shares for an estimated $1,285,080
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
APH Hedge Fund Activity
We have seen 979 institutional investors add shares of APH stock to their portfolio, and 872 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP removed 76,270,389 shares (-99.3%) from their portfolio in Q1 2026, for an estimated $9,636,763,650
- PRICE T ROWE ASSOCIATES INC /MD/ removed 11,736,160 shares (-30.9%) from their portfolio in Q1 2026, for an estimated $1,482,863,816
- CAPITAL INTERNATIONAL INVESTORS added 11,653,093 shares (+49.2%) to their portfolio in Q1 2026, for an estimated $1,472,368,300
- CAPITAL RESEARCH GLOBAL INVESTORS added 10,173,753 shares (+61.8%) to their portfolio in Q1 2026, for an estimated $1,285,453,691
- FMR LLC removed 6,943,274 shares (-8.0%) from their portfolio in Q1 2026, for an estimated $877,282,669
- NUVEEN, LLC added 5,322,488 shares (+68.2%) to their portfolio in Q1 2026, for an estimated $672,496,358
- BLACKROCK, INC. removed 4,171,540 shares (-3.9%) from their portfolio in Q1 2026, for an estimated $527,074,079
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
APH Analyst Ratings
Wall Street analysts have issued reports on $APH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 04/30/2026
- Citigroup issued a "Buy" rating on 01/12/2026
To track analyst ratings and price targets for APH, check out Quiver Quantitative's $APH forecast page.
APH Price Targets
Multiple analysts have issued price targets for $APH recently. We have seen 7 analysts offer price targets for $APH in the last 6 months, with a median target of $180.0.
Here are some recent targets:
- Guy Hardwick from Barclays set a target price of $180.0 on 05/04/2026
- William Stein from Truist Securities set a target price of $200.0 on 04/30/2026
- Amit Daryanani from Evercore ISI Group set a target price of $180.0 on 04/30/2026
- Asiya Merchant from Citigroup set a target price of $180.0 on 04/30/2026
- Samik Chatterjee from JP Morgan set a target price of $200.0 on 04/30/2026
- Joseph Spak from UBS set a target price of $178.0 on 04/30/2026
- Stephen Volkmann from Jefferies set a target price of $145.0 on 03/31/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
